Rovided funding.Received: 18 July 2016 Accepted: 31 JanuaryReferences 1. Deeks SG, Lewin SR, Havlir
Rovided funding.Received: 18 July 2016 Accepted: 31 JanuaryReferences 1. Deeks SG, Lewin SR, Havlir DV. The end of PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25681438 AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525?3. 2. Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, Francioli P, D’Arminio Monforte A, Fox Z, Lundgren JD, e group., EuroSIDA study. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16(12):1663?1. 3. Miro PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28154141 JM, Cofan F, Trullas JC, Manzardo C, Cervera C, Tuset M, Oppenheimer F, Brunet M, Moreno A, Campistol JM, Gatell JM. Renal dysfunction in the setting of HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(3):187?9. 4. Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD, e Group., EuroSIDA Study. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010;24(11):1667?8. 5. Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008; 335(2):89?4. 6. Lucas GM, Clarke W, Kagaayi J, Atta MG, Fine DM, Laeyendecker O, RP54476 clinical trials Serwadda D, Chen M, Wawer MJ, Gray RH. Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda. J Acquir Immune Defic Syndr. 2010;55(4):491?. 7. Sorl?ML, Guelar A, Montero M, Gonz ez A, Rodriguez E, Knobel H. Chronic kidney disease prevalence and risk factors among HIV-infected patients. J Acquir Immune Defic Syndr. 2008;48(4):506?. 8. Odongo P, Wanyama R, Obol JH, Apiyo P, Byakika-Kibwika P. Impaired renal function and associated risk factors in newly diagnosed HIV-infected adults in Gulu Hospital, Northern Uganda. BMC Nephrol. 2015;16:43. 9. Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. Endstage renal disease and chronic kidney disease in a cohort of AfricanAmerican HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21(18):2435?3.Cristelli et al. BMC Nephrology (2017) 18:Page 7 of10. Ryom L, Mocroft A, Lundgren J. HIV therapies and the kidney: some good, some not so good? Curr HIV/AIDS Rep. 2012;9(2):111?0. 11. Soveri I, Berg UB, Bj k J, Elinder CG, Grubb A, Mejare I, Sterner G, B k SE, SBU GFR Review Group. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64(3):411?4. 12. Delanaye P, Mariat C. The applicability of eGFR equations to different populations. Nat Rev Nephrol. 2013;9(9):513?2. 13. Gagneux-Brunon A, Delanaye P, Maillard N, Fresard A, Basset T, Alamartine E, Lucht F, Pottel H, Mariat C. Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort. AIDS. 2013;27(10):1573?1. 14. Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, Leppo M, Levey AS, Okparavero A, Graham H, Savage K, Schmid CH, Tighiouart H, Wallach F, Krishnasami Z. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr. 2012;61(3):302?. 15. Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC. Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014 Sep 17. [.
Nucleoside Analogues nucleoside-analogue.com
Just another WordPress site
